|
CNBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.947200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.481400E-01 |
| Normal-vs-Stage2 |
2.745800E-01 |
| Normal-vs-Stage3 |
4.518200E-02 |
| Normal-vs-Stage4 |
6.040000E-02 |
| Stage1-vs-Stage2 |
1.024580E-01 |
| Stage1-vs-Stage3 |
8.262100E-03 |
| Stage1-vs-Stage4 |
1.838120E-02 |
| Stage2-vs-Stage3 |
7.938400E-01 |
| Stage2-vs-Stage4 |
8.158800E-01 |
| Stage3-vs-Stage4 |
9.891000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.527200E-01 |
| Normal-vs-AfricanAmerican |
2.462400E-01 |
| Normal-vs-Asian |
5.590800E-01 |
| Caucasian-vs-AfricanAmerican |
5.299200E-01 |
| Caucasian-vs-Asian |
6.788400E-01 |
| AfricanAmerican-vs-Asian |
8.670600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.197500E-02 |
| Normal-vs-Female |
5.492600E-01 |
| Male-vs-Female |
1.449880E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.460800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.230400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.312000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.558200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.166400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.404800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.756380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.234200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.038000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.993600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.349650E-02 |
| Normal-vs-Grade 2 |
1.080030E-01 |
| Normal-vs-Grade 3 |
5.955700E-03 |
| Normal-vs-Grade 4 |
2.215900E-03 |
| Grade 1-vs-Grade 2 |
7.060200E-02 |
| Grade 1-vs-Grade 3 |
1.829010E-04 |
| Grade 1-vs-Grade 4 |
3.010900E-04 |
| Grade 2-vs-Grade 3 |
1.53037999999217E-05 |
| Grade 2-vs-Grade 4 |
3.52799999999709E-05 |
| Grade 3-vs-Grade 4 |
1.729020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.240700E-03 |
| Normal-vs-ccB subtype |
6.409100E-04 |
| ccA subtype-vs-ccB subtype |
2.30049979066393E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.024800E-01 |
| Normal-vs-N1 |
6.943500E-03 |
| N0-vs-N1 |
1.456210E-01 |
|
|
